Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptive drugs and devices market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Contraceptive Drugs And Devices Market reach by 2030 starting from 2026 levels?
The contraceptive drugs and devices market has experienced robust expansion in recent years. Its value is projected to increase from $26.98 billion in 2025 to $28.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market is attributable to government-led family planning initiatives, heightened awareness of reproductive health, rising urbanization and education levels, wider availability of oral contraceptives, and public health campaigns for birth control.
The contraceptive drugs and devices market is projected to experience substantial expansion in the coming years. This market is forecasted to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. The anticipated growth during this period is driven by factors such as enhanced digital health integration, a surge in demand for non-invasive contraceptive options, the broadening availability of telehealth prescriptions, an increased emphasis on male contraception research, and favorable reproductive health policies. Key trends for the projected timeframe encompass a growing uptake of long-acting reversible contraceptives, an uptick in the application of hormonal combination therapies, heightened demand for contraceptive solutions designed for women, the expansion of over-the-counter contraceptive offerings, and wider acceptance of digital platforms for contraception.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
Which Drivers Are Influencing Long-Term Growth In The Contraceptive Drugs And Devices Market?
The increasing number of government programs focused on reproductive health is projected to drive the growth of the contraceptive drugs and devices market in the future. Government initiatives actively promote reproductive well-being through public awareness efforts, financial provisions, and enhanced access to relevant services. These initiatives are expanding due to a growing recognition of the imperative to address critical concerns such as maternal health, family planning, and access to essential healthcare, which are fundamental for overall societal welfare and advancement. Furthermore, government initiatives for contraceptive drugs and devices are designed to increase the availability of affordable and effective family planning methods, enabling individuals to make educated choices regarding their reproductive health. An illustration of this is Australia’s plan, announced in November 2024 by the Australian Government Department of Foreign Affairs and Trade, to allocate $56.8 million towards a new project aimed at fostering sexual and reproductive health and rights across Southeast Asia. Therefore, the rising prevalence of government initiatives concerning reproductive health is a key factor expanding the contraceptive drugs and devices market.
Which Segments Are Driving Activity In The Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
What Long-Term Trends Are Expected To Shape The Future Of The Contraceptive Drugs And Devices Market?
Leading companies active in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible, contraceptive vaginal ring designed to be inserted into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control option that eliminates the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.
Which Major Firms Are Strengthening Their Position In The Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Shows The Strongest Potential For Future Expansion In The Contraceptive Drugs And Devices Market?
North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Contraceptive Drugs And Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp
Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company
Contraceptive Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report
Oral Contraceptive Pills Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model